Dianthus Therapeutics (DNTH) Research & Development (2017 - 2025)

Dianthus Therapeutics' Research & Development history runs 9 years deep, the most recent figure standing at $32.5 million for Q3 2025.

• In Q3 2025, Research & Development rose 27.19% year-over-year to $32.5 million; the TTM figure through Sep 2025 stood at $117.0 million (up 78.62% YoY), while the FY2024 annual figure was $87.9 million, up 167.65% from the prior year.
• Research & Development was $32.5 million for Q3 2025 at Dianthus Therapeutics, up from $26.3 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $32.5 million in Q3 2025 to a low of $5.8 million in Q1 2023.
• Historically, Research & Development has averaged $15.7 million across 5 years, with a median of $11.7 million in 2021.
• The sharpest annual moves came in 2023 and 2024: Research & Development slumped 64.66% in 2023, then jumped 255.4% in 2024.
• A 5-year view of Research & Development shows it stood at $13.1 million in 2021, then declined by 25.03% to $9.8 million in 2022, then slipped by 10.68% to $8.8 million in 2023, then surged by 255.4% to $31.2 million in 2024, then grew by 4.1% to $32.5 million in 2025.
• The last three Research & Development figures came in at $32.5 million (Q3 2025), $26.3 million (Q2 2025), and $27.0 million (Q1 2025), per Business Quant data.